44
Participants
Start Date
October 29, 2018
Primary Completion Date
October 15, 2021
Study Completion Date
October 15, 2021
Factor XIIa antagonist monoclonal antibody
Factor XIIa antagonist monoclonal antibody for intravenous and subcutaneous use
Placebo
Buffer without active ingredient
Campbelltown Hospital, Campbelltown
The Mount Sinai Hospital, New York
Charité Universitätsmedizin Berlin, Berlin
Pennsylvania State University, Hershey
Institute for Asthma and Allergy, Chevy Chase
Hautklinik und Poliklinik der Universitätsklinik Mainz, Mainz
Universitätsklinikum Frankfurt Goethe-Universität, Frankfurt
HZRM Hämophilie Zentrum Rhein Main GmbH, Mörfelden-Walldorf
AARA Research Center, Dallas
Immunoe Health Centers, Centennial
Donald S. Levy, Orange
Allergy & Asthma Clinical Research, Walnut Creek
Barzilai University Medical Center, Ashkelon
University of Alberta, Edmonton
Allergy and Clinical Immunology McMaster University, Hamilton
Ottawa Allergy Research Corp, Ottawa
Lead Sponsor
CSL Behring
INDUSTRY